Skip to main content

Table 1 Clinical characteristics of human subject

From: Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p/ATG2B/PTEN-AKT axis to mediate autophagy and pyroptosis

 

All

Healthy Control

NAFLD ( NAF = 2, NASH = 6)

P-value

n = 14

n = 6

n = 8

Age, years (mean ± S.D.)

49.07 ± 3.15

48.83 ± 3.13

49.25 ± 3.15

0.8241

Gender, male (n,%)

7 (50.00%)

2 (33.33%)

5 (62.50%)

0.5892

Serum ALT (U/l)

36.28 ± 15.10

19.15 ± 0.42

48.87 ± 5.39

0

Serum AST (U/l)

37.01 ± 14.79

20.90 ± 5.88

49.10 ± 3.98

0

  1. Bold and italics numbers indicate significant differences as P-value < 0.05
  2. Abbreviations: NAFLD Nonalcoholic fatty liver disease
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X